Cerity Partners LLC Sells 3,523 Shares of Integer Holdings Corporation (NYSE:ITGR)

Cerity Partners LLC cut its holdings in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 11.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 27,658 shares of the medical equipment provider's stock after selling 3,523 shares during the quarter. Cerity Partners LLC owned 0.08% of Integer worth $3,264,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Lee Danner & Bass Inc. purchased a new position in shares of Integer in the 4th quarter valued at $27,000. Opal Wealth Advisors LLC purchased a new position in shares of Integer in the 1st quarter valued at $28,000. AdvisorNet Financial Inc purchased a new position in shares of Integer in the 1st quarter valued at $28,000. Bessemer Group Inc. grew its position in shares of Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 125 shares during the last quarter. Finally, Sterling Capital Management LLC grew its position in shares of Integer by 472.9% in the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after buying an additional 279 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Raymond James Financial raised their price objective on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. KeyCorp cut their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, Benchmark lowered their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a report on Friday, April 25th. Two investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $146.25.

Integer Price Performance

Shares of NYSE:ITGR traded down $2.13 during trading hours on Friday, hitting $112.51. 463,003 shares of the company's stock traded hands, compared to its average volume of 390,078. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. The company's fifty day simple moving average is $119.65 and its two-hundred day simple moving average is $124.39. The company has a market cap of $3.93 billion, a price-to-earnings ratio of 53.32, a price-to-earnings-growth ratio of 0.97 and a beta of 0.98.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 4.38% and a return on equity of 11.95%. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period last year, the company posted $1.14 earnings per share. As a group, equities analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Insider Activity at Integer

In other news, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the transaction, the director owned 18,781 shares of the company's stock, valued at $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director directly owned 22,170 shares in the company, valued at approximately $2,672,815.20. This represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 362,434 shares of company stock valued at $44,577,115. 2.16% of the stock is currently owned by corporate insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.